Mettler-Toledo International, Inc. (NYSE:MTD) Shares Sold by Robeco Schweiz AG

Robeco Schweiz AG trimmed its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 14.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,864 shares of the medical instruments supplier's stock after selling 6,619 shares during the period. Robeco Schweiz AG owned 0.19% of Mettler-Toledo International worth $47,076,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of MTD. Alliancebernstein L.P. grew its stake in Mettler-Toledo International by 9.9% during the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock valued at $713,627,000 after acquiring an additional 52,726 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after purchasing an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Mettler-Toledo International by 6.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock valued at $557,680,000 after purchasing an additional 25,873 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after purchasing an additional 385,864 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its position in Mettler-Toledo International by 36.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock worth $444,327,000 after buying an additional 96,300 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MTD has been the subject of several analyst reports. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the stock an "outperform" rating in a research report on Tuesday. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their target price for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and a consensus price target of $1,280.90.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director owned 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock traded down $12.63 on Friday, reaching $1,223.62. The company had a trading volume of 118,779 shares, compared to its average volume of 150,546. The firm's 50 day moving average price is $1,165.26 and its two-hundred day moving average price is $1,195.29. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The firm has a market cap of $25.43 billion, a PE ratio of 30.51, a PEG ratio of 3.76 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter last year, the firm earned $8.89 EPS. The firm's revenue for the quarter was down 4.6% on a year-over-year basis. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.